Dravet parent survey on antiepileptic drugs

Families of patients with Dravet syndrome joined forces to carry out one of the largest scientific survey ever published for this rare disease.  In an unprecedented study, the Dravet Syndrome Foundation Spain surveyed 274 families from across Europe. One of the most important findings in our study is that 42% of the European patients are taking stiripentol, the only drug ever approved for this syndrome. The whole article is available online, in the journal Epilepsy and Behavior.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related works

DISCUSS Survey – results

DISCUSS Survey – results

→ Read more
Survey on falls in epilepsy

Survey on falls in epilepsy

→ Read more
SUDEP

SUDEP

→ Read more